Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Damn good article!
LITTLE ROCK, Ark. (Mar. 13, 2015) – An Arkansas bill that would nullify in practice some Food and Drug Administration (FDA) rules that prevent terminally ill patients from accessing treatments was signed into law by Governor Asa Hutchinson this week.
State Sen. John Cooper (R-21) introduced Senate Bill 4 (SB4) as the Arkansas Right to Try Act on Jan. 5. Passed unanimously by both houses, the new law is the latest pushback against the FDA and its controversial methodology of withholding experimental treatments from people on their deathbeds.
Right To Try allows terminally-ill Arkansans to try investigational treatments that have not received FDA approval to be on pharmacy shelves. Right To Try expands access to potentially life-saving treatments years before patients would normally be able to access them. The new law effectively nullifies this narrow, but important set of federal restrictions.
It reads, in part:
The standards of the United States Food and Drug Administration for the use of investigational drugs, biological products, and devices may deny the benefits of potentially life-saving treatments to terminally ill patients;
The State of Arkansas recognizes that patients who have a terminal disease have a fundamental right to attempt to pursue the preservation of their own lives by accessing available investigational drugs, biological products, and devices
“This new law is a no-brainer,” said Mike Maharrey of the Tenth Amendment Center. “When someone is on their deathbed, the fact that FDA regulations would let them die rather than try, has got to be one of the most inhumane policies of the federal government. Every state should nullify the FDA like this.”
The law provides protections for physicians who recommend or administer such treatments as well. It prohibits any licensing board from taking action to revoke, suspend, sanction, fail to renew, or take any other action against a physician’s license solely based on such physician’s recommendation, prescription, or treatment of an eligible patient with an investigational product. The law also provides immunity for manufacturers of these investigational drugs or treatments, except in the event of gross negligence or willful misconduct.
What is an SEC "notice of effectiveness"?
The notice of effectiveness is a public declaration by the Securities and Exchange Commission that a public company's registration statement has been accepted.
For shares in a public company to trade on the open market they must be registered by the company. These registration statements are reviewed by the Commission for a period of time before approval is given, and this notice marks the successful completion of this review process.
Thank you sir!
So, revolttoken.com says each dollar invested in revolt token is backed by 20 shares of ALYI. Sounds like an unhealthy circle.
GLTA
Who is the Letter of Intent signed with?
Thank you
Go Rockleo Go!!!!
Amen!
11.1
Reference Standard, Client Technology, Client Materials, Cell Line, and Product. SBL hereby understands and agrees that all rights to, titles of and interests in the Reference Standards, Client Technology, Client Materials, and Cell Line belong to Client, unless otherwise provided herein.
NNVC. No product. Nothing. Big time scam. IMHO
Thanks.
Graftech
Is Focus going to maintain ownership in Grafoid or is Brookfield taking it all?
From $48 to $56 since January 10!
Bali, been years since I checked in here. Glad you are still so positive. Hope this puppy hits the motherlode just for you! GLTA! Mikey.
Big spike in volume predicted. Russell 2000 here we come!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=102940919
It's a runner
32.80 after hours!
Starting to move.
Thanks fink!
Thank you!
Hacksaw, what's the basic difference between this stock and CQP?
Can any one explain the difference between this stock CQP and LNG? Thanks in advance.
"We got the goal," do you mean total depth or commercial oil? And welcome aboard!
Stopped out! Now that I have sold it will go back up. Glta!
I hear the company has gone "quiet" until 5/14.
Anybody know why Fidelity.com main stock quote page is now listing CWRN as "Cotton and Western Mining Inc. NEW"?
Mikey, I doubt any will expire worthless. Didn't happen before, the company just extended them. Not what we, as shareholders, want to see, but a nice deal for the PP folks.
Detonate, Did the same thing,when my case of CigRX ran out, I quit for a while. Didn't take long, back on the anatabloc from GNC.
Bali, a dollar?.. talk about a Purring PusSney!!! Hey, great name for a Yacht!
Falon, What do you think this will do to the share price? We were selling shares/warrants in the fourth quarter 2011 and first quarter 2012, which tell me we have no revenues. If the warrants get excercised in the third quarter, seems likely,that brings in about 1.3 million. When do you think we will see any revenue?
Warrants Exercise Expiration
Outstanding Price Date
----------- ----- ----
90,000,000 0.0025 16-Jul-2012
100,000,000 0.005 16-Jul-2012
194,059,960 0.005 16-Jul-2012
14,200,000 0.005 22-Dec-2012
35,642,852 0.006 22-Dec-2012
100,000,000 0.007 22-Dec-2012
1,200,000 0.0075 22-Dec-2012
6,000,000 0.007 31-Jan-2013
1,428,571 0.007 1-Feb-2013
1,500,000 0.007 4-Feb-2013
1,428,571 0.007 16-Mar-2013
-----------
Total 545,459,954
===========
RMC, Thanks for the info!! Long and strong!
GNC North Little Rock, Ar. Sold out!
Fidelity, $7.95/trade. No Problems.
Still here. Long & strong! Go SNEY!!!
Falon, This is another are earth explorer,Ucore. I wonder if this is where we are sending our samples?
"Three one tonne samples from alternative locations within the deposit were sent to Commodas Ultrasort of Wedel, Germany and processed by a full-scale production dual energy x-ray transmission sorter. Results show that 46% of the feed could
be rejected as waste with 93% recovery of rare earth oxides. This indicates the potential to have a significant positive effect on the capital and operating costs of the project. Further tests are underway to see if these results can be
further refined."
The German connection fits.
Enjoy your posts, Mike.
Kub, $7.95/trade w/Fidelity. No Problems.
50 day crossing 200 day,golden cross. Adding.
Liefsmith & Nukejohn, Great idea and thanks from a fellow investor.